Keywords: الو-HSCT; Immune privilege; CD47; CD274; Cytokine levels; Bone marrow; Stem cells; allo-HSCT; allogeneic hematopoietic stem cell transplantation; G-CSF; granulocyte - colony stimulating factor; PBSCs; peripheral blood stem cells; GVHD; graft-versus-host disease; cG
مقالات ISI الو-HSCT (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: الو-HSCT; Ocular graft-versus-host disease; Dry eye disease; Hematopoietic stem cell transplantation; Allo-HSCT; allogeneic hematological stem cell transplantation; BCVA; best corrected visual acuity; CsA; cyclosporin A; DED; dry eye disease; GVHD; graft-versus-hos
Keywords: الو-HSCT; aGvHD; acute graft-versus-host disease; allo-HSCT; allogeneic hematopoietic stem cell transplantation; ARG; antibiotic resistance gene; ATG; antithymocyte globulin; bp; base pair; cDNA; complementary DNA; RHM; reference healthy microbiome; contig; contigu
Keywords: الو-HSCT; Leukemia; Malnutrition; Soy protein; Whey protein; Protein intervention; PEM; Protein-energy malnutrition; HSCT; Hematopoietic stem cell transplantation; allo-HSCT; Allogeneic HSCT; BP; Soy-whey blended protein; ND; Natural diet; AML; Acute myeloid leukem
Keywords: الو-HSCT; HAdV; human adenovirus; allo-HSCT; allogeneic hematopoietic stem cell transplantation; PhHV; phocine herpesvirus; IC2; internal control (Adenovirus R-gene PCR Kit bioMérieux); Adenovirus; Stool; Diagnostics; DNA extraction; RQ-PCR;
Keywords: الو-HSCT; Allo-HSCT; QOL; Psycho-social issues; Family caregivers;
Keywords: الو-HSCT; Allo-HSCT; Bacteremia; Diversity; Intestinal microbiota; Microbial dominance; Metronidazole; Mortality; Survivalallo-HSCT, allogeneic HSCT; HSCT, hematopoietic stem cell transplantation; VRE, vancomycin-resistant Enterococcus
Sex-specific survival difference in association with HLA-DRB1â04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies
Keywords: الو-HSCT; Allogeneic HSCT; HLA allele groups; Lymphoid malignancy; Survival; HLA-DRB1â04; Allo-HSCT; allogeneic haematopoietic stem cell transplantation; ALL; acute lymphoid leukaemia; CI; confidence interval; CLL; chronic lymphoid leukaemia; CMV; cytomegalovirus
Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with hematological disorders: A retrospective analysis
Keywords: الو-HSCT; L-AMB; liposomal amphotericin B; allo-HSCT; allogeneic hematopoietic stem cell transplantation; eGFR; estimated glomerular filtration rate; CTCAE; Common Terminology Criteria for Adverse Events; HR; hazard ratios; OR; odds ratio; FEK; fractional excretion
Human CD134 (OX40) expressed on T cells plays a key role for human herpesvirus 6B replication after allogeneic hematopoietic stem cell transplantation
Keywords: الو-HSCT; HHV-6; human herpesvirus-6; PCR; polymerase chain reaction; allo-HSCT; allogeneic hematopoietic stem cell transplantation; UCBT; umbilical cord blood transplantation; GVHD; graft-versus-host disease; CD134; Hematopoietic stem cell transplantation; Human h
Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients
Keywords: الو-HSCT; aGvHD; acute graft versus host disease; ALC; absolute lymphocyte counts; Allo-HSCT; allogeneic hematopoietic stem cell transplantation; CMV; cytomegalovirus; TTV; Torque Teno virus; WBC; white blood cells; Torque Teno virus (TTV); TTV DNAemia; Allogeneic
Epstein-Barr virus DNA load kinetics analysis in allogeneic hematopoietic stem cell transplant recipients: Is it of any clinical usefulness?
Keywords: الو-HSCT; aGvHD; acute graft versus host disease; allo-HSCT; allogeneic hematopoietic stem cell transplantation; ATG; anti-thymocyte globulin; dt; doubling time; EBV; Epstein-Barr virus; PTLD; post-transplant lymphoproliferative disorders; Epstein-Barr (EBV); Plasm
Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus-Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration in a Mouse Model
Keywords: الو-HSCT; allo-HSCT; allogeneic hematopoietic stem cell transplantation; BM; bone marrow; CGVHD; chronic graft-versus-host disease; GVHD; graft-versus-host disease; HDF; human dermal fibroblast; LN; lymph node; MMP; matrix metalloproteinase; MSC; mesenchymal stem c
Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study
Keywords: الو-HSCT; allo-HSCT; allogeneic hematopoietic stem cell transplantation; IDA; idarubicin; AML; acute myeloid leukemia; ALL; acute lymphocytic leukemia; OS; overall survival; DFS; disease-free survival; RR; relapse rate; BU; busulfan; CY; cyclophosphamide; VP-16; et
Adoptive transfer of Aspergillus-specific T cells as a novel anti-fungal therapy for hematopoietic stem cell transplant recipients: Progress and challenges
Keywords: الو-HSCT; Ag; antigen; allo-HSCT; allogeneic hematopoietic stem cell transplantation; APCs; antigen presenting cells; Asp; Aspergillus; Asp-STs; Aspergillus-specific T cells; CAR; chimeric antigen receptor; cGMP; current good manufacturing practice; CMV; cytomegalo
MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28/B7 costimulatory pathway
Keywords: الو-HSCT; miRs; microRNAs; mRNA; messenger RNA; allo-HSCT; allogeneic hematopoietic stem cell transplantation; aGVHD; acute graft-versus-host disease; MicroRNA; T cell; CD28/B7 co-stimulatory signaling pathway; Inflammatory cytokine;
Comparison of outcomes of idarubicin intensified TBI-CY and traditional TBI-CY conditioning regimen for high-risk acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A single center experience
Keywords: الو-HSCT; ALL; acute lymphoblastic leukemia; allo-HSCT; allogeneic hematopoietic stem cell transplantation; TRM; transplant-related mortality; IDA; idarubicin; HR; hazard ratio; CI; confidence interval; NR; no remission; TBI; total body irradiation; CY; cyclophosph
A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia
Keywords: الو-HSCT; allo-HSCT; allogeneic hematopoietic stem cell transplantation; AML; acute myeloid leukemia; APC; allophycocyanin; CML; chronic myeloid leukemia; CFDA; 5,6-carboxyfluorescein diacetate succinimidyl ester; DLT; donor lymphocyte transfusions; ELISPOT; enzyme
Interesting possibilities to improve the safety and efficacy of ipilimumab (Yervoy)
Keywords: الو-HSCT; Breakdown; Efficacy; Improve; Ipilimumab; Tolerance; Safety; Yervoy; allo-HSCT; allogeneic hematopoietic stem cell transplantation; APC; antigen-presenting cell; CLL; chronic lymphocytic leukemia; CTLA-4; cytotoxic T lymphocyte-associated antigen-4; gp100
Reduced-Intensity Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: A Report from the SFGM-TC
Keywords: الو-HSCT; Allo-HSCT; RIC; Elderly patients; SFGM-TC; Age
Risk Factors for Progression from Cytomegalovirus Viremia to Cytomegalovirus Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Keywords: الو-HSCT; CMV disease; allo-HSCT; Leukopenia; Prediction
Brazilian green propolis and its constituent, Artepillin C inhibits allogeneic activated human CD4 T cells expansion and activation
Keywords: الو-HSCT; Allo-HSCT; allogeneic hematopoietic stem cell transplantation; APC; antigen presenting cells; Art-C; Artepillin C; CFSE; carboxyfluorescein succinimidyl ester; CsA; cyclosporine A; Foxp3; forkhead box p3; FK506; tacrolimus; GVHD; graft versus host disease
Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference
Keywords: الو-HSCT; shRNA; RNAi; CD28/B7; allo-HSCT; GVHD;